Eastman Chemical Framtida tillväxt
Future kriterier kontrolleras 1/6
Eastman Chemical förväntas öka intäkter och intäkter med 15.9% respektive 3% per år. EPS förväntas tillväxt med 16.7% per år. Avkastningen på eget kapital förväntas bli 13.5% om 3 år.
Viktig information
15.9%
Tillväxttakt i vinsten
16.68%
Tillväxttakt för EPS
| Chemicals vinsttillväxt | 17.2% |
| Intäkternas tillväxttakt | 3.0% |
| Framtida avkastning på eget kapital | 13.52% |
| Bevakning av analytiker | Good |
| Senast uppdaterad | 04 May 2026 |
Senaste uppdateringarna om framtida tillväxt
Recent updates
Analysartikel • May 09
Eastman Chemical's (NYSE:EMN) Soft Earnings Don't Show The Whole Picture
Eastman Chemical Company's ( NYSE:EMN ) stock was strong despite it releasing a soft earnings report last week. We...Seeking Alpha • May 04
Eastman Chemical: An Iran War Beneficiary
Summary Eastman Chemical remains a 'Buy,' benefiting from Middle East supply disruptions that are tightening markets and supporting price increases, especially in Chemical Intermediates. EMN expects Q2 EPS of $1.70–$1.90 and full-year EPS above $6, with free cash flow supporting a 4.3% dividend yield and $150 million in buybacks. Segment performance is mixed: Advanced Materials faces margin pressure, Additives & Functional sees stable growth, while Fibers is hit by tariffs and Middle East exposure. I target $6.25–$6.75 in 2024 EPS and a 12x multiple ($84 PT), with upside driven by sustained supply constraints and resilient end-market demand. Read the full article on Seeking Alpha
Uppdatering av berättelse • May 02
EMN: Supply Tightness And EV Glass Demand Will Support Earnings Recovery Potential
Analysts have made a modest upward adjustment to the Eastman Chemical price target to $96.01 from $95.39, reflecting updated views on the company following a mix of recent target hikes and one slight trim across major research firms. Analyst Commentary Recent Street research around Eastman Chemical has been active, with a cluster of price target changes and at least one upgrade, alongside a single modest trim.Uppdatering av berättelse • Apr 18
EMN: Supply Tightness And Completed Buybacks Will Support Earnings Recovery Potential
Analysts have modestly raised their fair value estimate for Eastman Chemical to $95.39. This reflects updated price targets and recent research that points to slightly stronger revenue growth and profitability assumptions.
Uppdatering av berättelse • Apr 04
EMN: Future Earnings Recovery Will Struggle With Persistent Commodity Oversupply
Analyst price targets for Eastman Chemical have shifted higher by several dollars into the mid $70s to mid $80s range, as analysts factor in updated commodity chemical forecasts, evolving geopolitical supply constraints, and a slightly adjusted risk profile reflected in modest tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Eastman Chemical over recent months has featured a mix of higher price targets and recalibrated views on risk, as firms respond to commodity market forecasts, geopolitical bottlenecks in key shipping routes, and sector wide concerns around capacity and demand.Uppdatering av berättelse • Mar 20
EMN: Supply Disruptions And Cash Returns Will Support Earnings Recovery Potential
Analysts nudged the fair value estimate for Eastman Chemical higher from $90.83 to $92.24, citing updated commodity chemical forecasts tied to supply disruptions and refined assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Eastman Chemical has leaned constructive, with several bullish analysts updating price targets and assumptions in response to both company specific factors and shifts in commodity markets.Uppdatering av berättelse • Mar 05
EMN: Modest Upside As Oversupply And Deindustrialization Restrain Earnings Recovery Potential
Analysts have lifted their average price targets on Eastman Chemical by a mid single digit dollar range, with moves such as Evercore ISI taking its target to $75 from $70, as they factor in slightly different views on long term growth, profitability and valuation multiples, reflected in modest adjustments to revenue growth, profit margin, discount rate and future P/E assumptions. Analyst Commentary While several firms have nudged price targets higher on Eastman Chemical, there is also a thread of caution running through recent research that is worth keeping in mind when you think about risk and reward.Uppdatering av berättelse • Feb 19
EMN: Cost Actions And Cash Returns Will Support Earnings Recovery Potential
Analysts have nudged their fair value estimate for Eastman Chemical up by about $1 to $90.83, pointing to refreshed assumptions around modestly positive revenue growth, a slightly lower discount rate, and a marginally reduced future P/E multiple as key drivers behind recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of upward price target revisions for Eastman Chemical, even as some firms fine tune assumptions to reflect mixed end markets.Uppdatering av berättelse • Feb 04
EMN: Oversupplied Commodity Markets Will Constrain Future Earnings Recovery Potential
Analysts have raised their fair value estimate for Eastman Chemical from $60.00 to $67.00. This reflects updated assumptions for revenue growth, profit margins, and a higher future P/E multiple, following a series of recent price target increases across the Street.Uppdatering av berättelse • Jan 21
EMN: Cost Savings And Free Cash Flow Will Support Earnings Recovery Potential
Narrative Update Analysts have trimmed their consolidated price expectations for Eastman Chemical by around $1. They are factoring in softer revenue growth assumptions, slightly lower future P/E multiples, and a mixed set of recent target changes that balance cautious industry views with confidence in cash generation and margin resilience.Uppdatering av berättelse • Jan 07
EMN: Cost Savings And Asset Utilization Will Drive Earnings Recovery Potential
Analysts have trimmed their fair value estimate for Eastman Chemical to about $90 from roughly $95, reflecting slightly higher discount rate assumptions and somewhat softer profit margin expectations. They still point to cost savings, asset utilization ramps and solid free cash flow as key supports for their updated price targets around $73 to $75.Analysartikel • Jan 05
These 4 Measures Indicate That Eastman Chemical (NYSE:EMN) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Uppdatering av berättelse • Dec 23
EMN: Cost Savings And Asset Utilization Will Support Stronger Free Cash Flow
Analysts have nudged their average price target for Eastman Chemical slightly higher to about $73 from roughly $72.75, citing expectations for 2026 earnings tailwinds from cost savings, improved asset utilization, and resilient free cash flow even through a sluggish demand backdrop. Analyst Commentary Bullish analysts highlight that, despite modest adjustments to price targets, the long term investment case for Eastman Chemical remains underpinned by 2026 earnings tailwinds, including structural cost savings and improved asset utilization that are expected to drive margin expansion and profit growth from 2025 onward.Uppdatering av berättelse • Dec 09
EMN: Cost Savings And Asset Utilization Will Drive Earnings Higher From 2025
Analysts have modestly trimmed their price target on Eastman Chemical by about $2 per share to approximately $74, citing a still challenging macro backdrop but highlighting improving 2026 earnings visibility driven by cost savings, asset utilization tailwinds, and the company’s ability to sustain solid free cash flow through the current earnings trough. Analyst Commentary Recent Street commentary reflects a generally constructive stance on Eastman Chemical, with price targets clustered in the low to mid 70s and Buy ratings maintained even as estimates and targets are adjusted to reflect a tougher macro environment.Uppdatering av berättelse • Nov 25
EMN: Cost Savings And Asset Utilization Will Drive Earnings From 2025
The average analyst price target for Eastman Chemical has edged slightly lower to approximately $73, down less than $1, as analysts cite both resilient free cash flow and ongoing cost-saving initiatives in the context of a mixed demand outlook. Analyst Commentary Recent analyst updates reflect a nuanced perspective on Eastman Chemical's outlook, with both bullish and bearish takeaways emerging from the latest price target revisions and research commentary.Uppdatering av berättelse • Nov 09
EMN: Cost Savings And Asset Utilization Will Drive Earnings Upside Ahead
Eastman Chemical's analyst price target was adjusted slightly downward by $1.53 to $73.06, as analysts cite a focus on cash generation and persistent end-market sluggishness, even though earnings improvements are expected ahead. Analyst Commentary Recent analyst updates on Eastman Chemical reflect a mix of cautious optimism and ongoing concerns related to the company's valuation and execution in a challenging market environment.Uppdatering av berättelse • Oct 26
Commodity End Markets And Recycling Initiatives Will Shape Recovery Prospects Ahead
Eastman Chemical's analyst price target has been reduced by approximately $1 to $74.59. Analysts cite persistent macro headwinds and weakening conditions in commodity and industrial end markets as key factors behind this revised outlook.Uppdatering av berättelse • Oct 12
Molecular Recycling And Specialty Materials Will Expand Global Reach
Analysts have lowered their price target for Eastman Chemical from $86 to $75, citing expectations of softer revenue growth and a moderately higher discount rate. Analyst Commentary Bullish Takeaways Bullish analysts continue to maintain a Buy rating on Eastman Chemical, citing confidence in the company's longer-term fundamentals.Analysartikel • Aug 02
Eastman Chemical Company (NYSE:EMN) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Eastman Chemical Company ( NYSE:EMN ) shareholders that were waiting for something to happen have been dealt a blow...Analysartikel • Jun 18
We Think Eastman Chemical (NYSE:EMN) Can Stay On Top Of Its Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 26
Following Up On A Correctly-Rated Eastman Chemical Company In 2025 (Rating Upgrade)
Summary Eastman Chemical has underperformed recently but shows promise with improved valuation and strategic direction, making it a conservative "Buy" for 2025. The company’s strong fundamentals, diverse product portfolio, and focus on sustainability, especially in molecular recycling, position it well for future growth. Despite recent declines, Eastman’s operational improvements, share buybacks, and favorable macro trends suggest significant upside potential, with expected earnings growth in the coming years. I rate Eastman Chemical a "Buy" at a valuation target of $140/share, anticipating a 15% annualized return based on a 12.2x P/E multiple. Read the full article on Seeking AlphaSeeking Alpha • Oct 14
Eastman Chemical: Difficult To See Upside At This Valuation (Rating Downgrade)
Summary Eastman Chemical Company has shown strong 2Q24 results, particularly in advanced materials, but its current valuation appears overvalued, leading to a “Hold” rating. The company's strategic focus on specialty products and de-commoditization, along with new assets, has improved margins and operational performance. Despite positive trends, macroeconomic pressures and weak underlying demand outside destocking pose challenges, with limited upside potential at the current valuation. Eastman Chemical remains a fundamentally sound and ESG-focused company, but better investment opportunities exist in the market, warranting caution. Read the full article on Seeking Alpha
Ny berättelse • Aug 22
Transforming Challenges Into Opportunities With Green Chemical Recycling And Innovative Growth
Expansion in sustainable solutions like chemical recycling and the Tritan product line indicates potential for revenue growth and market share increase.Seeking Alpha • Jul 10
Eastman Chemical Running In Place (Rating Downgrade)
Summary Eastman Chemical is a $11.1 billion market cap specialty chemicals company offering a 3.4% dividend. The company’s new focus is on molecular (plastic) recycling. It has just opened a plant in Tennessee and received a US government grant to build one in Texas. Eastman’s second-largest number of plants are in high-cost Europe (nine). However, it is geographically diversified with 16 US plants and several in Asia and Latin America. Read the full article on Seeking AlphaPrognoser för vinst- och omsättningstillväxt
| Datum | Intäkter | Intäkter | Fritt kassaflöde | Kassaflöde från rörelsen | Genomsnittligt Antal analytiker |
|---|---|---|---|---|---|
| 12/31/2028 | 9,682 | 835 | 768 | 1,258 | 10 |
| 12/31/2027 | 9,424 | 787 | 724 | 1,157 | 13 |
| 12/31/2026 | 9,170 | 720 | 667 | 1,087 | 13 |
| 3/31/2026 | 8,639 | 399 | 498 | 1,000 | N/A |
| 12/31/2025 | 8,752 | 474 | 424 | 970 | N/A |
| 9/30/2025 | 9,024 | 699 | 395 | 1,008 | N/A |
| 6/30/2025 | 9,286 | 832 | 406 | 1,002 | N/A |
| 3/31/2025 | 9,362 | 922 | 575 | 1,136 | N/A |
| 12/31/2024 | 9,382 | 905 | 688 | 1,287 | N/A |
| 9/30/2024 | 9,344 | 885 | 604 | 1,199 | N/A |
| 6/30/2024 | 9,147 | 883 | 606 | 1,317 | N/A |
| 3/31/2024 | 9,108 | 925 | 523 | 1,360 | N/A |
| 12/31/2023 | 9,210 | 894 | 546 | 1,374 | N/A |
| 9/30/2023 | 9,376 | 585 | 520 | 1,379 | N/A |
| 6/30/2023 | 9,818 | 708 | 334 | 1,121 | N/A |
| 3/31/2023 | 10,278 | 692 | 271 | 956 | N/A |
| 12/31/2022 | 10,580 | 793 | 364 | 975 | N/A |
| 9/30/2022 | 10,901 | 1,170 | 285 | 948 | N/A |
| 6/30/2022 | 10,912 | 1,220 | 617 | 1,239 | N/A |
| 3/31/2022 | 10,781 | 818 | 824 | 1,420 | N/A |
| 12/31/2021 | 10,476 | 857 | 1,041 | 1,619 | N/A |
| 9/30/2021 | 9,968 | 511 | 1,144 | 1,595 | N/A |
| 6/30/2021 | 9,370 | 321 | 1,084 | 1,490 | N/A |
| 3/31/2021 | 8,641 | 494 | 1,108 | 1,500 | N/A |
| 12/31/2020 | 8,473 | 478 | 1,059 | 1,455 | N/A |
| 9/30/2020 | 8,492 | 472 | 1,325 | 1,720 | N/A |
| 6/30/2020 | 8,695 | 577 | 1,267 | 1,694 | N/A |
| 3/31/2020 | 9,134 | 808 | 1,260 | 1,680 | N/A |
| 12/31/2019 | 9,273 | 759 | N/A | 1,504 | N/A |
| 9/30/2019 | 9,444 | 767 | N/A | 1,573 | N/A |
| 6/30/2019 | 9,666 | 913 | N/A | 1,552 | N/A |
| 3/31/2019 | 9,924 | 999 | N/A | 1,573 | N/A |
| 12/31/2018 | 10,151 | 1,080 | N/A | 1,543 | N/A |
| 9/30/2018 | 10,137 | 1,537 | N/A | 1,449 | N/A |
| 6/30/2018 | 10,055 | 1,448 | N/A | 1,582 | N/A |
| 3/31/2018 | 9,853 | 1,396 | N/A | 1,570 | N/A |
| 12/31/2017 | 9,549 | 1,384 | N/A | 1,657 | N/A |
| 9/30/2017 | 9,375 | 1,009 | N/A | 1,401 | N/A |
| 6/30/2017 | 9,197 | 918 | N/A | 1,323 | N/A |
| 3/31/2017 | 9,075 | 881 | N/A | 1,386 | N/A |
| 12/31/2016 | 9,008 | 854 | N/A | 1,385 | N/A |
| 9/30/2016 | 9,045 | 862 | N/A | 1,569 | N/A |
| 6/30/2016 | 9,205 | 886 | N/A | 1,487 | N/A |
| 3/31/2016 | 9,441 | 928 | N/A | 1,584 | N/A |
| 12/31/2015 | 9,648 | 848 | N/A | 1,624 | N/A |
| 9/30/2015 | 9,772 | 740 | N/A | 1,509 | N/A |
| 6/30/2015 | 9,738 | 694 | N/A | 1,701 | N/A |
Analytiker Framtid Tillväxt Prognoser
Intäkter kontra sparande: EMN s prognostiserade vinsttillväxt ( 15.9% per år) är över sparkvoten ( 3.5% ).
Resultat vs marknad: EMN s intäkter ( 15.9% per år) förväntas växa långsammare än marknaden för US ( 16.8% per år).
Höga tillväxtresultat: EMN s intäkter förväntas växa, men inte avsevärt.
Intäkt vs marknad: EMN s intäkter ( 3% per år) förväntas växa långsammare än marknaden för US ( 11.7% per år).
Hög tillväxtintäkter: EMN s intäkter ( 3% per år) förväntas växa långsammare än 20% per år.
Tillväxtprognoser för vinst per aktie
Framtida avkastning på eget kapital
Framtida ROE: EMN s avkastning på eget kapital förväntas bli låg om 3 år ( 13.5 %).
Upptäck tillväxtföretag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/22 12:04 |
| Aktiekurs vid dagens slut | 2026/05/22 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Eastman Chemical Company bevakas av 36 analytiker. 13 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Sergey Vasnetsov | Barclays |
| Michael Leithead | Barclays |
| Paretosh Misra | Berenberg |